Received Mar 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Z005570 | IM |
Patient experienced a febrile seizure 8 days following vaccine administration. On day 9 post-vaccination, the patient developed a diffuse systemic rash.
none
none
nkda